Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2024 · 51 positions · Total reported value $123.78M · Top-10 concentration 59.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Stonepine Capital Management, LLC disclosed 51 equity positions with a combined reported value of $123.78M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.0% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were ADMA ($21.28M), EOLS ($13.96M), TELA ($7.11M). By sector, the heaviest allocations are Health Care 82.7%, Other 17.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.6pp) and away from Other (-5.6pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 54% of names.

The largest new positions opened in Q4 2024 were IKT ($3.68M), INO ($1.92M), ENTA ($1.91M).

Of the 29 positions fully exited versus the prior quarter, the largest were RPRX ($6.00M), RIGL ($5.00M), ARQT ($822.65K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • IKT INHIBIKASE THERAPEUTICS INC · $3.68M
  • INO INOVIO PHARMACEUTICALS INC · $1.92M
  • ENTA ENANTA PHARMACEUTICALS INC · $1.91M
  • CALC CALCIMEDICA INC · $1.66M
  • PROF PROFOUND MED CORP · $1.50M
  • VIR VIR BIOTECHNOLOGY INC · $1.20M
  • ANIP ANI PHARMACEUTICALS INC · $1.13M
  • HRTX HERON THERAPEUTICS INC · $1.07M

Fully Exited (vs previous quarter)

  • RPRX ROYALTY PHARMA PLC · prev qtr: $6.00M
  • RIGL RIGEL PHARMACEUTICALS INC · prev qtr: $5.00M
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · prev qtr: $822.65K
  • FNA PARAGON 28 INC · prev qtr: $766.36K
  • TENX TENAX THERAPEUTICS INC · prev qtr: $173.00K · history
  • VIRX VIRACTA THERAPEUTICS INC · prev qtr: $115.70K

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.7%
Other 17.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.24M $21.28M 17.20%
17.20%
Reduce
2 1.26M $13.96M 11.28%
11.28%
Reduce
3 2.35M $7.11M 5.74%
5.74%
Add
4 200.00K $5.50M 4.44%
4.44%
Reduce
5 597.70K $4.98M 4.03%
4.03%
Reduce
6 870.00K $4.50M 3.63%
3.63%
Reduce
7 220.00K $4.04M 3.26%
3.26%
Add
8 588.66K $3.93M 3.18%
3.18%
Reduce
9 238.22K $3.92M 3.17%
3.17%
Add
10 305.00K $3.79M 3.06%
3.06%
Add
11 80.00K $3.69M 2.98%
2.98%
Add
12 1.13M $3.68M 2.97%
2.97%
New
13 324.32K $3.45M 2.79%
2.79%
Add
14 125.70K $3.30M 2.67%
2.67%
Reduce
15 235.00K $2.98M 2.40%
2.40%
Add
16 648.78K $2.87M 2.32%
2.32%
Reduce
17 683.53K $2.42M 1.96%
1.96%
Reduce
18 137.20K $1.97M 1.59%
1.59%
Add
19 1.05M $1.92M 1.55%
1.55%
New
20 331.90K $1.91M 1.54%
1.54%
New
21 274.43K $1.77M 1.43%
1.43%
Add
22 468.79K $1.66M 1.34%
1.34%
New
23 663.40K $1.65M 1.33%
1.33%
Reduce
24 200.00K $1.50M 1.21%
1.21%
New
25 10.00K $1.23M 0.99%
0.99%
Reduce
26 164.11K $1.20M 0.97%
0.97%
New
27 500.00K $1.18M 0.95%
0.95%
Reduce
28 20.40K $1.13M 0.91%
0.91%
New
29 700.00K $1.07M 0.86%
0.86%
New
30 251.05K $1.03M 0.83%
0.83%
Reduce
31 300.00K $882.00K 0.71%
0.71%
Add
32 110.00K $844.80K 0.68%
0.68%
Add
33 535.80K $809.07K 0.65%
0.65%
New
34 110.00K $739.20K 0.60%
0.60%
Reduce
35 407.55K $692.83K 0.56%
0.56%
Reduce
36 700.00K $673.40K 0.54%
0.54%
Add
37 200.97K $663.20K 0.54%
0.54%
Reduce
38 182.32K $618.05K 0.50%
0.50%
New
39 160.00K $569.60K 0.46%
0.46%
New
40 149.22K $490.94K 0.40%
0.40%
Add
41 132.87K $417.21K 0.34%
0.34%
New
42 250.00K $345.00K 0.28%
0.28%
New
43 103.67K $315.15K 0.26%
0.26%
Reduce
44 132.35K $273.96K 0.22%
0.22%
New
45 196.73K $271.49K 0.22%
0.22%
New
46 25.00K $119.75K 0.10%
0.10%
New
47 200.00K $112.52K 0.09%
0.09%
New
48 15.00K $109.80K 0.09%
0.09%
New
49 67.29K $78.73K 0.06%
0.06%
New
50 23.26K $70.72K 0.06%
0.06%
Reduce

FAQ

What did Stonepine Capital Management, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, Stonepine Capital Management, LLC reported 51 equity positions worth $123.78M in aggregate; its largest disclosed positions were ADMA ($21.28M), EOLS ($13.96M), TELA ($7.11M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $123.78M of long equity holdings across 51 positions as of 2024-Q4. Top-10 holdings account for 59.0% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →